Related Experiment Video
Updated: Aug 29, 2025
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.2K
Utilization of Palliative Care in Osteosarcoma: A National Cancer Database Review
Kevin M McMahon1, Vincent P Eaton1, Gregory J Cichon1
1School of Medicine, Creighton University, Omaha, NE, USA.
The American Journal of Hospice & Palliative Care
|September 6, 2022
Summary
Palliative care utilization remains low for osteosarcoma patients, despite increasing use with advanced tumor stage or size. Further research is needed to expand palliative care (PC) access for bone cancer patients.
Area of Science:
- Oncology
- Palliative Care
- Health Services Research
Background:
- Osteosarcoma is the most common primary bone cancer.
- Palliative care (PC) utilization in osteosarcoma patients is understudied.
- The National Cancer Database (NCDB) was used to investigate PC use.
Purpose of the Study:
- To investigate the utilization of palliative care in osteosarcoma patients.
- To identify factors associated with palliative care use in this population.
- To establish baseline data on palliative care patterns in osteosarcoma.
Main Methods:
- Analysis of osteosarcoma patients (2004-2017) from the NCDB.
- Cross-tabulations and Chi-square tests for frequency analysis.
- Multivariate logistic regression to identify predictors of PC use.
Main Results:
- Only 2.8% of 7498 osteosarcoma patients received palliative care.
- PC use increased with tumor stage (IV), size, and midline bone location.
- PC use decreased with distance from facility, private insurance, and specific tumor subtypes.
Conclusions:
- Palliative care use in osteosarcoma is notably low.
- Utilization is associated with tumor characteristics but remains limited.
- Further studies are required to understand and enhance PC access for osteosarcoma patients.
Related Concept Videos
01:21Cancer Survival Analysis
429
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
429
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K